Interview with Francisco Billano, President, Interphil Laboratories
Interphil Laboratories has been active in the Philippines for a long time, having started in 1975 with the merger between Muller & Phipps. Can you give to our readers an…
Address: Canlubang Industrial Estate, Bo Pittland, 4025 Cabuyao, Laguna ,Philippines
Tel: +63 49 549-2345
Web: http://www.pharmaindustries.com/pi_home.html
Interphil Laboratories is a pharmaceutical contract manufacturer with a client-base of over 50 multinational companies, producing a wide range of healthcare products in many different forms, all in accordance with global standards. We have over 1,200 formulations currently in production in the largest, most advanced contract manufacturing facility in Asia.
Meeting the demands of our clients, Interphil Laboratories adheres to the highest standards of Quality Assurance. Our corporate policy of cGMP (current Good Manufacturing Practice) compliance is strictly enforced to ensure that the highest quality standards are applied in the preparation of only the safest, most efficacious products.
Interphil Laboratories has maintained a policy of not owning a proprietary brand in favor of safeguarding the confidentiality of clients’ manufacturing formulae.
Interphil Laboratories was born of the merger in 1978 between Pharma Industries Inc., a Zuellig-owned company established in the 1950’s, and Muller and Phipps, a US-owned company established in the 1940’s. The merged company was called Interphil and went public on the Philippines Stock Exchange in 1978.
Interphil Laboratories supports the supply chain of our clients with three core services: Product Development, Planning and Procurement and Contract Manufacturing. These services supply a competitive advantage for our clients by increasing available revenue streams, lowering costs and expanding a responsive production capacity.
Product development:
This service allows clients to develop line extensions and new pack sizes, and to receive assistance in the documentation licensing of existing formulations.
Planning & procurement:
This service offers clients customized materials, logistics planning and the benefits of group purchasing programs.
Toll manufacturing:
The multiple production facilities make possible the replication of manufacturing and packaging processes based on clients’ specifications.
Interphil Laboratories has been active in the Philippines for a long time, having started in 1975 with the merger between Muller & Phipps. Can you give to our readers an…
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
Ramon Aristoza, acting President and CEO of PhilHealth, discusses the current challenges the organization is facing in terms of realizing the goal of universal healthcare for the Filipino population, their…
The election of maverick former mayor of Davao, Rodrigo Duterte to the Filipino presidency in May 2016 represented a dramatic departure from politics as usual and raised interesting questions about…
Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets,…
Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and…
Javish Abichandani, Chief Executive Officer of AGlobal Care Inc. in the Philippines, outlines the company’s extensive product portfolio as well as their ambitions to bring more high-quality, affordable medications into…
Jose Augusto Pascual, President and CEO of PascualLab, sheds light on the company’s current footprint in the Philippines, as well as their ambitions to even further expand their manufacturing capabilities.…
Cheryl Maley, General Manager of Novartis Philippines, discusses the company’s operations in the country, their growing portfolio of products as well as their impressive focus on research and development in…
Meneleo Hernandez, Jr., President of Multicare, describes Lupin Pharma’s Multicare operations in the Philippines and how their niche business unit strategy and strategic partnerships create a sustainable business model that…
Ivan Alexi Arota, country manager of GE Healthcare Philippines, discusses the company’s extensive efforts to increase access to their innovative, affordable products throughout the country. He also expands on the…
Bakhuti Shengelia, Director Healthcare Systems of Novartis International AG, expands on Novartis’ initiatives to increase access to healthcare in emerging markets as well as the importance of transitioning towards value-based…
See our Cookie Privacy Policy Here